Loading Events

« All Events

State drug price transparency reporting for emerging life sciences companies

September 21, 2021 @ 12:00 pm - 1:00 pm EDT

Free
Baker Tilly CPE Webinars

Participants of the live webinar will be eligible for 1 free CPE credit.

Register

What to know before the launch of your first product

Drug prices within the U.S. continue to be a point of discussion with consumers, lawmakers and professionals throughout the healthcare industry. As of mid-2021, 21 states have enacted price transparency reporting requirement laws for pharmaceutical manufacturers, and with more states continuing to propose additional laws and regulations, the need to analyze and understand reporting obligations has never been greater. This is especially true for emerging pharmaceutical and biotech companies traversing the murky waters of varying reporting requirements when launching their first product.

Join Baker Tilly for an informative presentation about state drug price transparency reporting requirements for life sciences companies that are about to launch their first product. Our colleagues will discuss:

  • The past, present and future state of state drug price transparency reporting
  • An understanding of what requirements emerging life sciences companies should be aware of before the launch of a new product
  • A high-level overview of select state price transparency requirements
  • Challenges and strategies to consider when navigating proprietary information, potential penalties and labor intensiveness of compliance

Who should attend?

  • C-Suite, legal, regulatory affairs, medical affairs, quality and safety, internal audit, and compliance and monitoring professionals at emerging and established life sciences companies

Presenters

  • Erica Petersohn, Senior Manager, Baker Tilly
  • Ashley Jones, JD, Legal Consultant, Baker Tilly

Learning objectives

  • Understand the past, present and future state of state drug price transparency reporting
  • Develop an understanding of what requirements emerging life sciences companies should be aware of before the launch of a new product
  • Know an overview of select state price transparency requirements
  • Identify challenges and strategies to consider when navigating proprietary information, potential penalties and labor intensiveness of compliance

Information about CPE eligibility

There are no prerequisites for this webinar, and advance preparation is not required. There is no cost to attend this webinar.

Level: Overview

CPE credit: One (1) hour total credit

Field of study: Management Advisory Services

A certificate of completion will be emailed to you four to six weeks after the event.

For more information regarding administrative policies such as complaint and refund, please contact our offices at +1 (608) 240 2522.

NASBA logo

Baker Tilly US, LLP is registered with the National Association of State Boards of Accountancy (NASBA) as a sponsor of continuing professional education on the National Registry of CPE Sponsors. State boards of accountancy have final authority on the acceptance of individual courses for CPE credit. Complaints regarding registered sponsors may be submitted to the National Registry of CPE Sponsors through its website: learningmarket.org.

Leave a Reply

Subscribe Here